ATG5 and neoplasm: Mechanistically, SH3BGRL binds with ATG5 and stabilizes it to drive the basal liver cell autophagy through inhibition of Src and its downstream ERK and AKT signaling pathways that generally lead to tumor cell survival and proliferation.